As a content writer and startup analyst, I believe that Molport's innovative approach to simplifying the process of accessing the global compound marketplace has the potential to make significant contributions to the field of drug discovery and biotechnology.
Molport
Easily access the global R&D chemical marketplace. Buy screening compounds and building blocks via our smart platform.
Founded 2006
Latvia
21 employees
Venture round
Total: $1.09M
Biotechnology
Latvia
21 employees
Venture round
Total: $1.09M
Biotechnology
General Information
Company Name
Molport
Founded Year
2006
Location
Latvia
Latvia
Employees
21
Industries
Biotechnology
Funding Stage
Venture round
BounceWatch is an independent company data service, not affiliated with Molport. To contact Molport, visit molport.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Molport compare?
A PDF of Molport and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Molport soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Latvia Market
Biotechnology
About Molport
Business keywords: Chemical sourcing, Drug discovery, Compound procurement, Research and development, Biotech industry, Chemical marketplace, Scientific community, Custom synthesis, Screening compounds, Building blocks, Data-driven tools, Global market access, Procurement solutions, Research efficiency, Specialized chemical sourcing
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | €500.00K | 2 |
|
19 Jan 2015 |
| Venture Round | €485.00K | 2 |
|
22 Apr 2013 |
| Seed Round | €100.00K | 1 |
|
10 Dec 2010 |
Molport Alternatives & Competitors
View All Alternatives
Molport vs
Specs, part of eMolecules, Inc.
The Netherlands
Specs is the world's leading provider of compound management services and supplier of research compo...
57 employees
Biotechnology
Molport vs
Axxam
Italy
Translating innovative biology into bioactive molecules
Grant
197 employees
Biotechnology, Medical Devices
Molport vs
-logo.jpg "Advanced ChemBlocks Inc (AChemBlock)"){kind=logo}
Advanced ChemBlocks Inc (AChemBlock)
United States
Leading chemical supplier based in the San Francisco Bay Area
3 employees
Biotechnology, Food and Beverage
FAQ About Molport
Easily access the global R&D chemical marketplace. Buy screening compounds and building blocks via our smart platform.
Molport was founded in 2006.
Molport is headquartered in Latvia.
Molport operates in Biotechnology. Its work centres on Chemical sourcing, Drug discovery, Compound procurement and Research and development.
Molport has approximately 21 employees.
Molport has completed 3 funding rounds, raising a total of $1.09M. The latest funding stage is Venture round.
Top alternatives and competitors to Molport include Specs, part of eMolecules, Inc., Axxam, Advanced ChemBlocks Inc (AChemBlock), Altis Biosystems, Complegen Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Molport and Specs, part of eMolecules, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Molport, https://bouncewatch.com/company/molport, updated 30 November 2024. When citing, please name BounceWatch and link this page.
